|
|
.
NPI Detail
NPI: 1811984388
Type: Organization
Taxonomy Code: 282N00000X
Hospital-General
Hospitals/General Acute Care Hospital
2501 XXXXXX XXX
ZION, IL 600992587
Business phone: (XXX) XXX-XXXX
Mailing address phone: (XXX) XXX-XXXX
|
Click here for new NPI search.
|
2021 OPPS Part A Medicare Services Submitted NPI-1811984388*
OPPS Payment Method "A" - Services not paid under OPPS; uses a different fee schedule (e.g., ambulance, PT, mammography)
Top Level I HCPC Procedures
| Procedure | Description | Number Submitted | Medicare Payment |
| 85025
|
COMPLETE CBC W/AUTO DIFF WBC
|
XXXX
|
$XXXX.XX
|
| 80053
|
COMPREHEN METABOLIC PANEL
|
XXXX
|
$XXXX.XX
|
| 36415
|
ROUTINE VENIPUNCTURE
|
XXXX
|
$XXX
|
Top Drugs Administered Other than Oral Method
| Procedure | Description | Number Submitted | Medicare Payment |
| J1453
|
Fosaprepitant injection
|
XXXXXX
|
$XXXXX.XX
|
| J9271
|
Inj pembrolizumab
|
XXXXX
|
$XXXXXXX.XX
|
| J9263
|
Oxaliplatin
|
XXXXX
|
-
|
| J2704
|
Inj, propofol, 10 mg
|
XXXXX
|
-
|
| J9299
|
Injection, nivolumab
|
XXXXX
|
$XXXXXX.XX
|
| J9267
|
Paclitaxel injection
|
XXXXX
|
-
|
| J9306
|
Injection, pertuzumab, 1 mg
|
XXXXX
|
$XXXXXX.XX
|
| J0897
|
Denosumab injection
|
XXXXX
|
$XXXXXX.XX
|
| J9358
|
Inj fam-trastu deru-nxki 1mg
|
XXXXX
|
$XXXXXX.XX
|
| J9264
|
Paclitaxel protein bound
|
XXXXX
|
$XXXXXX.XX
|
| J1100
|
Dexamethasone sodium phos
|
XXXXX
|
-
|
| J9144
|
Daratumumab, hyaluronidase
|
XXXXX
|
$XXXXXX.XX
|
| J1439
|
Inj ferric carboxymaltos 1mg
|
XXXXX
|
$XXXX.XX
|
| J9317
|
Sacituzumab govitecan-hziy
|
XXXXX
|
$XXXXXX.XX
|
| J0461
|
Atropine sulfate injection
|
XXXXX
|
-
|
| J2469
|
Palonosetron hcl
|
XXXX
|
-
|
| J9305
|
Inj. pemetrexed nos 10mg
|
XXXX
|
$XXXXXX.XX
|
| J9173
|
Inj., durvalumab, 10 mg
|
XXXX
|
$XXXXXX.XX
|
| J9171
|
Docetaxel injection
|
XXXX
|
-
|
| J8540
|
Oral dexamethasone
|
XXXX
|
-
|
| J0894
|
Decitabine injection
|
XXXX
|
$XXXXX.XX
|
| J0640
|
Leucovorin calcium injection
|
XXXX
|
-
|
| J9047
|
Injection, carfilzomib, 1 mg
|
XXXX
|
$XXXXXX.XX
|
| J9155
|
Degarelix injection
|
XXXX
|
$XXXXX.XX
|
| J9311
|
Inj rituximab, hyaluronidase
|
XXXX
|
$XXXXXX.XX
|
| J0131
|
Inj, acetaminophen (nos)
|
XXXX
|
-
|
| J2350
|
Injection, ocrelizumab, 1 mg
|
XXXX
|
$XXXXXX.XX
|
| J9349
|
Inj., tafasitamab-cxix
|
XXXX
|
$XXXXX.XX
|
| J9308
|
Injection, ramucirumab
|
XXXX
|
$XXXXXX.XX
|
| J3480
|
Inj potassium chloride
|
XXXX
|
-
|
| J2795
|
Ropivacaine hcl injection
|
XXXX
|
-
|
Top HCPC Level II Procedures / Professional Services
| Procedure | Description | Number Submitted | Medicare Payment |
| G0463
|
Hospital outpt clinic visit
|
XXXX
|
$XXXXXX.XX
|
* Medicare Part A utilization data is derived from the 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
|
